Transgenic mice as a source of fully human antibodies for the treatment of cancer

Cancer and Metastasis Reviews

Volumn 18, Issue 4, 1999, Pages 421-425

  Davis, C Geoffrey ^a   Gallo, Michael L ^a   Corvalan, Jose R F ^a  

^a Abgenix Inc   (United States)

Author keywords

Cancer; Epidermal growth factor receptor; Human antibodies; Transgenic

Indexed keywords

CANCER ANTIBODY; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; MONOCLONAL ANTIBODY; RITUXIMAB; TRASTUZUMAB;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIBODY PRODUCTION; ARTICLE; CANCER IMMUNOTHERAPY; GENETIC ENGINEERING; LYMPHOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECOMBINANT FUSION PROTEINS;

EID: 0033512662     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006321231510     Document Type: Article

References (10)

1. 1. Leget GA, Czuczman MS: Use of rituximab, the new FDA-approved antibody. Curr Opin Oncol 10: 548-551, 1998
2. 2. Goldenberg MM: Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer. Clin Ther 21: 309-318, 1999
3. 3. Abramowicz D, Crusiaux A, Goldman M: Anaphylactic shock after retreatment with OKT3 monoclonal antibody. N Engl J Med 327: 736, 1992
4. 4. Morrison SL, Oi VT: Chimeric Immunoglobulin Genes, Immunoglobulin Genes. Academic Press, London, 1989, p. 260
5. 5. Riechmann L, Clark M, Waldmann H, Winter G: Reshaping human antibodies for therapy. Nature 332: 323-327, 1988
6. 6. Green LL, Jakobovits A: Regulation of B cell development by variable gene complexity in mice reconstituted with human immunoglobulin yeast artificial chromosomes. J Exp Med 188: 483-495, 1998
7. 7. Yang X-D, Corvalan JRF, Wang P, Roy CM-N, Davis CG: Fully human anti-interleukin-8 monoclonal antibodies: potential therapeutics for the treatment of inflammatory disease states. J Leukoc Biol 66: 401-410, 1999
8. 8. Mendez MJ, Green LL, Corvalan JRF, Jia X-C, Maynard-Currie CE, Yang X-D, Gallo ML, Louie DM, Lee DV, Erickson KL, Luna J, Roy CM-N, Abderrahim H, Kirsehenbaum F, Noguchi M, Smith DH, Fukushima A, Hales JF, Finer MH, Davis CG, Zsebo KM, Jakobovits A: Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice. Nat Genetics 15: 146-156, 1997
9. 9. Brezinschek HP, Brezinschek RI, Lipsky PE: Analysis of the heavy chain repertoire of human peripheral B cells using single-cell polymerase chain reaction. J Immunol 155: 190-202, 1995
10. 10. Yang X-Y, Jia X-C, Corvalan JRF, Wang P, Davis CG, Jakobovits A: Eradication of established tumors by a fully human monoclonal antibody to the epidermal growth factor receptor without concomitant chemotherapy. Cancer Res 59: 1236-1243, 1999